Effectiveness Study of Integrative Treatment for Pediatric Community Acquired Pneumonia
- Conditions
- Pneumonia
- Interventions
- Drug: phlegm-heat formula granulesDrug: second generation cephalosporinDrug: Fu-xiong San
- Registration Number
- NCT02362906
- Brief Summary
- The purpose of this study is to evaluate the effectiveness of traditional Chinese medicine for treatment of pediatric pneumonia. It is a multicenter randomized controlled trial. 
- Detailed Description
- The block randomization is used in this trial. Random numbers are generated by statistical analysis system(SAS) software. Statistical analysis staff and those who perform the follow-up are blinded. Sample size calculation was performed, which was 1164 , and considering drop-out or withdrawal, investigators plan to enroll 1500 patients (500 in experimental group 1, 500 in experimental group 2, 500 in experimental group 3). 
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 1500
- children,aged 1 to 14 years old;
- diagnosed as pneumonia according to western medicine diagnostic criteria;
- diagnosed as TCM pneumonia with pneumonia with dyspnea and cough, meeting wind-heat blocking lungs pattern (feng re bi fei zheng), and phlegm-heat blocking lungs pattern(tan re bi fei zheng);
- disease progression within 72 hours; those whose guardians understood and assigned the informed consent;
- severe pneumonia;
- complicated with other Pulmonary Disorders attack other than pneumonia;
- complicated with primary disease of heart(congenital heart disease, myocarditis, et al),liver(alanine aminotransferase(ALT),and aspartate transaminase(AST) ≥1.5 times of normal value ceiling),kidney (blood urea nitrogen(BUN) >8.2mmol/l, or serum C reactive protein >104umol/l,et al) and blood system (anemia) ,and those with psychopathy;
- allergic to interventional medications; those who are participating or have participated in other clinical trials in 3 months;
- those who intend to lost follow-up by practitioners' judgment.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
- Group - Intervention - Description - Injection,medications and application - Xiyanping injection - Intravenous injection: bacterial pneumonia: second generation cephalosporin; mycoplasma pneumonia: erythromycin or azithromycin; viral pneumonia: Xiyanping injection, produced by Jiangxi Qing Feng Pharmaceutical Co.,Ltd; Medications: according to TCM syndrome differentiations; Wind-heat blocking lungs pattern(feng re bi fei zheng): wind-heat formula granules; phlegm-heat blocking lungs pattern(tan re bi fei zheng): phlegm-heat formula granules; external application: Fu-xiong San. - Injection and medications - second generation cephalosporin - Intravenous injection: bacterial pneumonia:second generation cephalosporin; mycoplasma pneumonia:erythromycin or azithromycin; viral pneumonia:Xiyanping injection, produced by Jiangxi Qing Feng Pharmaceutical Co.,Ltd; Medications: according to TCM syndrome differentiations; Wind-heat blocking lungs pattern(feng re bi fei zheng): wind-heat formula granules; phlegm-heat blocking lungs pattern(tan re bi fei zheng): phlegm-heat formula granules. - Injection and application - Xiyanping injection - Intravenous injection: bacterial pneumonia: second generation cephalosporin; mycoplasma pneumonia: erythromycin or azithromycin; viral pneumonia: Xiyanping injection, produced by Jiangxi Qing Feng Pharmaceutical Co.,Ltd; external application: Fu-xiong San. - Injection,medications and application - Fu-xiong San - Intravenous injection: bacterial pneumonia: second generation cephalosporin; mycoplasma pneumonia: erythromycin or azithromycin; viral pneumonia: Xiyanping injection, produced by Jiangxi Qing Feng Pharmaceutical Co.,Ltd; Medications: according to TCM syndrome differentiations; Wind-heat blocking lungs pattern(feng re bi fei zheng): wind-heat formula granules; phlegm-heat blocking lungs pattern(tan re bi fei zheng): phlegm-heat formula granules; external application: Fu-xiong San. - Injection,medications and application - phlegm-heat formula granules - Intravenous injection: bacterial pneumonia: second generation cephalosporin; mycoplasma pneumonia: erythromycin or azithromycin; viral pneumonia: Xiyanping injection, produced by Jiangxi Qing Feng Pharmaceutical Co.,Ltd; Medications: according to TCM syndrome differentiations; Wind-heat blocking lungs pattern(feng re bi fei zheng): wind-heat formula granules; phlegm-heat blocking lungs pattern(tan re bi fei zheng): phlegm-heat formula granules; external application: Fu-xiong San. - Injection and medications - phlegm-heat formula granules - Intravenous injection: bacterial pneumonia:second generation cephalosporin; mycoplasma pneumonia:erythromycin or azithromycin; viral pneumonia:Xiyanping injection, produced by Jiangxi Qing Feng Pharmaceutical Co.,Ltd; Medications: according to TCM syndrome differentiations; Wind-heat blocking lungs pattern(feng re bi fei zheng): wind-heat formula granules; phlegm-heat blocking lungs pattern(tan re bi fei zheng): phlegm-heat formula granules. - Injection and application - Fu-xiong San - Intravenous injection: bacterial pneumonia: second generation cephalosporin; mycoplasma pneumonia: erythromycin or azithromycin; viral pneumonia: Xiyanping injection, produced by Jiangxi Qing Feng Pharmaceutical Co.,Ltd; external application: Fu-xiong San. - Injection,medications and application - second generation cephalosporin - Intravenous injection: bacterial pneumonia: second generation cephalosporin; mycoplasma pneumonia: erythromycin or azithromycin; viral pneumonia: Xiyanping injection, produced by Jiangxi Qing Feng Pharmaceutical Co.,Ltd; Medications: according to TCM syndrome differentiations; Wind-heat blocking lungs pattern(feng re bi fei zheng): wind-heat formula granules; phlegm-heat blocking lungs pattern(tan re bi fei zheng): phlegm-heat formula granules; external application: Fu-xiong San. - Injection and medications - Xiyanping injection - Intravenous injection: bacterial pneumonia:second generation cephalosporin; mycoplasma pneumonia:erythromycin or azithromycin; viral pneumonia:Xiyanping injection, produced by Jiangxi Qing Feng Pharmaceutical Co.,Ltd; Medications: according to TCM syndrome differentiations; Wind-heat blocking lungs pattern(feng re bi fei zheng): wind-heat formula granules; phlegm-heat blocking lungs pattern(tan re bi fei zheng): phlegm-heat formula granules. - Injection and application - second generation cephalosporin - Intravenous injection: bacterial pneumonia: second generation cephalosporin; mycoplasma pneumonia: erythromycin or azithromycin; viral pneumonia: Xiyanping injection, produced by Jiangxi Qing Feng Pharmaceutical Co.,Ltd; external application: Fu-xiong San. - Injection,medications and application - wind-heat formula granules - Intravenous injection: bacterial pneumonia: second generation cephalosporin; mycoplasma pneumonia: erythromycin or azithromycin; viral pneumonia: Xiyanping injection, produced by Jiangxi Qing Feng Pharmaceutical Co.,Ltd; Medications: according to TCM syndrome differentiations; Wind-heat blocking lungs pattern(feng re bi fei zheng): wind-heat formula granules; phlegm-heat blocking lungs pattern(tan re bi fei zheng): phlegm-heat formula granules; external application: Fu-xiong San. - Injection and medications - wind-heat formula granules - Intravenous injection: bacterial pneumonia:second generation cephalosporin; mycoplasma pneumonia:erythromycin or azithromycin; viral pneumonia:Xiyanping injection, produced by Jiangxi Qing Feng Pharmaceutical Co.,Ltd; Medications: according to TCM syndrome differentiations; Wind-heat blocking lungs pattern(feng re bi fei zheng): wind-heat formula granules; phlegm-heat blocking lungs pattern(tan re bi fei zheng): phlegm-heat formula granules. - Injection,medications and application - Erythromycin - Intravenous injection: bacterial pneumonia: second generation cephalosporin; mycoplasma pneumonia: erythromycin or azithromycin; viral pneumonia: Xiyanping injection, produced by Jiangxi Qing Feng Pharmaceutical Co.,Ltd; Medications: according to TCM syndrome differentiations; Wind-heat blocking lungs pattern(feng re bi fei zheng): wind-heat formula granules; phlegm-heat blocking lungs pattern(tan re bi fei zheng): phlegm-heat formula granules; external application: Fu-xiong San. - Injection,medications and application - Azithromycin - Intravenous injection: bacterial pneumonia: second generation cephalosporin; mycoplasma pneumonia: erythromycin or azithromycin; viral pneumonia: Xiyanping injection, produced by Jiangxi Qing Feng Pharmaceutical Co.,Ltd; Medications: according to TCM syndrome differentiations; Wind-heat blocking lungs pattern(feng re bi fei zheng): wind-heat formula granules; phlegm-heat blocking lungs pattern(tan re bi fei zheng): phlegm-heat formula granules; external application: Fu-xiong San. - Injection and medications - Erythromycin - Intravenous injection: bacterial pneumonia:second generation cephalosporin; mycoplasma pneumonia:erythromycin or azithromycin; viral pneumonia:Xiyanping injection, produced by Jiangxi Qing Feng Pharmaceutical Co.,Ltd; Medications: according to TCM syndrome differentiations; Wind-heat blocking lungs pattern(feng re bi fei zheng): wind-heat formula granules; phlegm-heat blocking lungs pattern(tan re bi fei zheng): phlegm-heat formula granules. - Injection and medications - Azithromycin - Intravenous injection: bacterial pneumonia:second generation cephalosporin; mycoplasma pneumonia:erythromycin or azithromycin; viral pneumonia:Xiyanping injection, produced by Jiangxi Qing Feng Pharmaceutical Co.,Ltd; Medications: according to TCM syndrome differentiations; Wind-heat blocking lungs pattern(feng re bi fei zheng): wind-heat formula granules; phlegm-heat blocking lungs pattern(tan re bi fei zheng): phlegm-heat formula granules. - Injection and application - Azithromycin - Intravenous injection: bacterial pneumonia: second generation cephalosporin; mycoplasma pneumonia: erythromycin or azithromycin; viral pneumonia: Xiyanping injection, produced by Jiangxi Qing Feng Pharmaceutical Co.,Ltd; external application: Fu-xiong San. - Injection and application - Erythromycin - Intravenous injection: bacterial pneumonia: second generation cephalosporin; mycoplasma pneumonia: erythromycin or azithromycin; viral pneumonia: Xiyanping injection, produced by Jiangxi Qing Feng Pharmaceutical Co.,Ltd; external application: Fu-xiong San. 
- Primary Outcome Measures
- Name - Time - Method - Cured rate (clinical symptoms and signs totally disappear, the period of lab tests return to normal is recorded) - every day since receiving treatment,all together 7 days (times) - clinical symptoms and signs totally disappear, the period of lab tests return to normal is recorded - effective time window (days range from treatment is received to the effectiveness is observed, and symptoms disappear) - every day since receiving treatment, all together 7 days (times) - days range from treatment is received to the effectiveness is observed, and symptoms disappear 
- Secondary Outcome Measures
- Name - Time - Method - effect in treating fever - 7 days - temperature, fever frequency,fever lasting time, Ibuprofen Suspension, all to be measured - effect in phlegm releasing - 7 days - phlegm amount,color and nature to be measured - effect in dyspnea releasing - 7 days - gasp frequency, severity, all to be measured - effect in cough releasing - 7 days - cough severity to be measured - time from admission to recovery of rales - 7 days - TCM syndrome scores - 7 days - measure is a composite. - effective rate of TCM syndrome scores - 7 days - total effecive rate according to TCM syndrome differentiation and treatment, and single syndrome effective rate - check-out time (days counted when the patient checks out) - 7 days - days counted when the patient checks out - pulmonary disease incidence (prolonged pneumonia, chronic cough, cough variant asthma incidence in the follow-up) - 15 days; 30 days; 90 days - prolonged pneumonia, chronic cough, cough variant asthma incidence in the follow-up - safety (With adverse events as the calculation basis) - 7 days - With adverse events as the calculation basis 
Trial Locations
- Locations (10)
- Affiliated Children's Hospital of Capital University of Medical Sciences 🇨🇳- Beijing, Beijing, China - Guangzhou Children's Hospital 🇨🇳- Guangzhou, Guangdong, China - Affiliated hospital of Guangzhou university of Chinese Medicine 🇨🇳- Guangzhou, Guangdong, China - Affiliated Hospital of Guangxi University of Chinese Medicine 🇨🇳- Nanning, Guangxi, China - Affiliated Hospital of Changchun University of TCM 🇨🇳- Changchun, Jilin, China - Affiliated Children's Hospital of Dalian Medical University 🇨🇳- Dalian, Liaoning, China - Affiliated Hospital of Liaoning University of TCM 🇨🇳- Shenyang, Liaoning, China - Affiliated Hospital of Shandong University of TCM 🇨🇳- Ji'nan, Shandong, China - Affiliated Longhua Hospital of Shanghai University of TCM 🇨🇳- Shanghai, Shanghai, China - First teaching hospital of Tianjin university of TCM 🇨🇳- Tianjin, Tianjin, China Affiliated Children's Hospital of Capital University of Medical Sciences🇨🇳Beijing, Beijing, ChinaKunling Shen, Ph. DPrincipal Investigator
